Ireland
--:--IST
Recruiting Not applicable

Qigong and Multicomponent Exercise in Panic Disorder

NCT07439224 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2024-12-01
Last updated
2026-08-25

Condition(s) studied

Panic DisorderPanic Disorder (With or Without Agoraphobia)Panic Attacks and DisordersQigongExerciseAnxiety Disorders

Investigational drug(s) / intervention(s)

Exercise Training

Exercise Training: Exercise training for 8 weeks

Study summary

Panic disorder is a psychiatric disease characterized by recurrent panic attacks that occur in expected or unexpected situations and create feelings of intense fear, restlessness and discomfort. Panic disorder often has a chronic course, its frequency and severity can be irregular, various physical, mental, and behavioral symptoms can develop, and the quality of life of individuals can decrease significantly. Evidence-based psychotherapy and pharmacotherapy are effective in reducing the symptoms of panic disorder and managing the disorder. However, both of these treatment methods have certain limitations, and approximately one-third of patients do not respond to therapy or the response is not sufficiently effective. Delaying treatment of the disease results in a poor prognosis and more established symptoms. Exercise can be viewed as a low-cost, supportive treatment for relieving symptoms with comparable efficacy to medication and other psychological interventions. Although exercise is recommended for patients with anxiety-panic disorder, there remains uncertainty about whether its effects are sustainable, the type and intensity of exercise required for effective treatment, and thus the effects of qigong and multicomponent exercise on multiple health outcomes in panic disorder. The aim of this study is to examine the effects of Qigong exercise training and multicomponent exercise training on anxiety-panic, balance, mobility, walking, functional strength, physical activity, sleep quality, fatigue, chronic musculoskeletal pain, quality of life and cognition.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being between the ages of 18-65 * Being diagnosed with "panic disorder" by a psychiatrist * Not having another psychiatric illness * Wanting to participate in the research voluntarily and signing the informed consent * Not having a history of communication or neuromusculoskeletal disease that would not allow the application of evaluation and treatment methods Exclusion Criteria: * Having a vision and/or hearing problem that would prevent participation in the study * History of neurological, cardiopulmonary and musculoskeletal system disease that would negatively affect participation in evaluation and treatment

Primary outcome measure(s)

  • DSM-5 Panic Disorder Severity Scale — change from baseline to 8 weeks
    Panic levels will be evaluated with the DSM-5 Panic Disorder Severity Scale. It provides a five-point Likert-type rating (0=never, 1=sometimes, 2=half of the time, 3=most of the time, 4=all of the time). Scores obtained from the scale items determine the severity of panic disorder. The total score for the scale ranges from 0 to 40, with higher scores indicating more severe panic disorder symptoms.
  • State-Trait Anxiety Inventory — change from baseline to 8 weeks
    State and trait anxiety levels will be assessed with the State-Trait Anxiety Inventory. The State-Trait Anxiety Inventory is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety separately in two forms (STAI-S; STAI-T)-state anxiety and trait anxiety. The scale has 20 state-domain and 20 trait-domain questions. A score of 1 indicates that the situation described in the question does not reflect their personality at all; a score of 4 indicates that the situation described in the question reflects their personality completely. Each form is scored between 20 and 80, with higher scores positively correlated with higher anxiety levels, while lower scores indicate lower anxiety levels. The cutoff score for this scale is 44, with scores of 45 and above indicating higher anxiety levels.

Trial sites (1)

FacilityCityRegionStatus
Dokuz Eylul University Izmir Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07439224 on ClinicalTrials.gov ↗ ← All trials in Turkey